← Open Payments lookup

CAROLYN BAILEY: Open Payments

NPI 1487384855 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,369 in 77 payments from 15 companies in 2025. Trend: 2023 $1,421 · 2024 $1,154 · 2025 $1,369

Food & beverage: $1,252Education: $118
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$293
ABBVIE INC.21$255
Alkermes, Inc.9$143
Vanda Pharmaceuticals Inc.8$138
Teva Pharmaceuticals USA, Inc.1$111
Takeda Pharmaceuticals U.S.A., Inc.4$75
Janssen Pharmaceuticals, Inc4$74
Corium, LLC2$63
E.R. Squibb & Sons, L.L.C.3$62
Axsome Therapeutics, Inc.2$39

Products named: INGREZZA, VRAYLAR, ARISTADA, FANAPT, TRINTELLIX, Azstarys, COBENFY, INVEGA SUSTENNA.

Industry payments across LA — which companies pay providers there.